Jacobs Levy Equity Management, Inc Agios Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$21.38 - $29.19 $10 Million - $13.7 Million	-469,922 Reduced 76.47%	144,611 $4.1 Million
Q1 2023 May 15, 2023	BUY	$21.74 - $30.93 $3.17 Million - $4.51 Million	145,787 Added 31.1%	614,533 $14.1 Million
Q4 2022 Feb 14, 2023	SELL	$24.81 - $31.52 $446,083 - $566,729	-17,980 Reduced 3.69%	468,746 $13.2 Million
Q3 2022 Nov 15, 2022	BUY	$19.51 - $34.14 $1.75 Million - $3.06 Million	89,711 Added 22.6%	486,726 $13.8 Million
Q2 2022 Aug 15, 2022	SELL	$17.06 - $31.42 $1.17 Million - $2.16 Million	-68,837 Reduced 14.78%	397,015 $8.8 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $34.81 $4.21 Million - $5.49 Million	157,811 Added 51.23%	465,852 $13.6 Million
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $162,512 - $273,491	5,494 Added 1.82%	308,041 $10.1 Million
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $3.54 Million - $4.92 Million	84,525 Added 38.77%	302,547 $14 Million
Q2 2021 Aug 16, 2021	BUY	$52.06 - $61.27 $767,676 - $903,487	14,746 Added 7.25%	218,022 $12 Million
Q1 2021 May 17, 2021	BUY	$44.23 - $57.5 $3.83 Million - $4.98 Million	86,690 Added 74.36%	203,276 $10.5 Million
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $654,270 - $916,884	-19,701 Reduced 14.46%	116,586 $5.05 Million
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $3.12 Million - $5.15 Million	92,090 Added 208.36%	136,287 $4.77 Million
Q2 2020 Aug 17, 2020	BUY	$34.45 - $53.48 $1.52 Million - $2.36 Million	44,197 New	44,197 $2.36 Million
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $927,365 - $1.34 Million	-15,500 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$52.12 - $72.33 $807,860 - $1.12 Million	15,500	15,500 $886,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

Farallon Capital Management LLC San Francisco, CA

5.66M
Shares

$195 Million
1.26% of portfolio
Vanguard Group Inc Valley Forge, PA

5.55M
Shares

$191 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$167 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.74M
Shares

$129 Million
2.8% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.83M
Shares

$97.5 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account